McDermott + Bull has been engaged to lead the search of Miromatrix Medical, Inc.’s next Vice President of Cellular Manufacturing and Technical Operations. This search will be led by McDermott + Bull Managing Partner Ken Dropiewski and Senior Executive Recruiter Quyen Doan.
Miromatrix Medical, Inc., fresh off its successful IPO, is a fast-growing regenerative medicine company in the industry. Supported by some of the biggest names in healthcare, Miromatrix is on a mission to eliminate the organ transplant list. With an average of 22 people dying each day waiting for a transplant, the need for a solution is dire. Founded in 2009, they continue to be the world leader in bringing the promise of fully biologic organs to those who need them most.
Miromatrix is looking for its next Vice President of Cellular Manufacturing and Technical Operations to provide leadership to an organization responsible for manufacturing, developing, and optimizing a regenerative medicinal product using human tissues and cells. As the leader of all the manufacturing and developmental functions, this role represents a single point of accountability for advancing Miromatrix’s regenerative medicine product pipeline. The company is seeking an individual with manufacturing expertise in cellular therapies, gene therapies, or tissue to scale up capabilities for this game-changing product.
If you know of anyone who might be a good fit for the role, please contact Quyen Doan at doan@mbexec.com.